Immunoassay Market
Immunoassay Market Analysis by Technology Type (Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)), by Product Type (Analyzer, Consumables), by Application Type, by End-User - Global Forecast 2022 to 2032
Analysis of Immunoassay market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Immunoassay Market Outlook (2022 to 2032)
The global immunoassay market is forecast to grow at a 6% value CAGR, during the forecast period 2022-2032, reaching a market value of US$ 53 Billion. In 2021, the market was valued at US$ 28 Billion, and is likely to reach US$ 29.6 Billion in 2022, registering a Y-o-Y growth rate of 5.7%.
A growing number of chronic and infectious diseases, including COVID-19, can be attributed to market growth. Additionally, the growing geriatric population, which is more susceptible to chronic and infectious diseases, will contribute to growth.
| Report Attributes | Details |
|---|---|
| Base Year Value (2021) | US$ 28 Billion |
| Current Year Value (2022) | US$ 29.6 Billion |
| Forecast Value (2032) | US$ 53 Billion |
| Global Growth Rate (2022-2032) | 6% CAGR |
| Market Share of North America (2021) | 35% |
| Market Share of Asia Pacific (2021) | 34% |
| Key Companies Profiled | DiaSorin S.p.A.; Sysmex Corporation; bioMerieux SA; Ortho Clinical Diagnostics; Thermo Fisher Scientific Inc.; Becton; Dickinson and Company ; Merck KGaA. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
2015 to 2021 Demand Analysis of Immunoassay Industry vs. Future Outlook 2022 to 2032
According to Fact.MR- a market research and competitive intelligence provider- Immunoassay industry growth totaled to a CAGR of 5.2% from 2015 to 2021. An increase in chronic and infectious diseases, including COVID-19, can be attributed to the market growth. Moreover, the rise in geriatric populations, who are more susceptible to chronic and infectious diseases, will increase the market growth.
A rise in chronic diseases such as cancer, cardiovascular disease, infections, autoimmune disease, nephrological diseases and diabetes mellitus, has led to the wide use of immunoassay techniques in disease diagnostics. The incidence of cancer is growing steadily, driving the need for effective diagnostic methods such as immunoassays.
Oncogenesis and cancer diagnosis are crucial aspects of this technique, whether benign or malignant. By determining the presence of tumor antigens, it facilitates the use of monoclonal or polyclonal antibodies that can identify specific antigens in tissues.
Growing research and development efforts, as well as an increase in cancer markers, disease diagnostics, clinical research methods, cardiac analysis, therapeutic medication monitoring are projected to fuel market growth. Biochemical tests, such as immunoassays, can be performed in hospitals and medical laboratories to determine whether certain chemicals are present and their concentrations.
Immunoassays are used in numerous bioanalytical applications including medical diagnosis, biopharmaceutical analysis, environmental monitoring, and food testing, which is driving the market's growth. From 2022 to 2032, the global market is forecast to expand 1.8x.
Prominent Growth Drivers Influencing Immunoassay Industry
Chronic Diseases and Public Awareness is expected to propel the market growth
Globally, chronic conditions such as diabetes, cardiovascular disease, and cancer are on the rise. A number of infectious diseases are still on the rise, including SARS-CoV2 (COVID-19), Dengue, Hepatitis B and C, HIV, malaria, tuberculosis, and many more.
Immunoassay diagnosis has become a critical part of the diagnostic process of many of these diseases. Advances in immunoassay technology offer faster results, higher sensitivity, and lower detection limits, while reducing costs. Worldwide immunoassay market growth is being fueled by the widespread use of quick tests and point-of-care tests for disease diagnosis and alcohol and drug addiction.
An effective part of controlling epidemic diseases is public awareness campaigns designed to identify symptoms of infectious diseases and ways to prevent them. Immunoassays have therefore been in high demand due to increased patient awareness.
The International Society of Infectious Diseases' advocacy program, for instance, aims to collaborate with public health practitioners, clinicians, and researchers worldwide and to support the exchange of scientific knowledge and evidence-based medicine practices.
Furthermore, the World Hepatitis Alliance launched the "Find the Missing Millions" campaign as part of its efforts to raise awareness about hepatitis and remove barriers in clinical diagnostic settings.
Technological Advancements to Provide Traction to Immunoassay Adoption
A technical and skilled workforce is required to interpret diagnostic tests. Assay analyzers play an important role in this process. The interpretation of assay results depends on how quickly they are completed. With innovations in the field of technology, the immunoassay market has been greatly elevated.
A number of automated laboratory instruments and equipment have been developed as a result of technological advancements. Laboratories benefit from automation because of increased efficiency and reduced space and labor usage. Thus, the market is experiencing substantial growth as some players are offering automated laboratory systems and point-of-care tests that are compact, portable.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What could Possibly Hinder Immunoassay Deployment?
Strict regulations and technological challenges affect the growth of this market
Regulatory agencies in various countries have imposed strict requirements for the licensing and marketing of immunoassay consumables and equipment. The growth of the immunoassay market is also slowed by technological challenges such as cross-reactivity of antibodies, false negatives, limited detection limits of available antibodies, and others.
Immunoassay technicians encounter numerous design issues, such as misinterpretation of results. Moreover, the clinical diagnostics industry has been plagued by a shortage of qualified experts for many decades, which has hindered the market.
Region-wise Analysis
What is the Demand Outlook for Immunoassay in North America?
Increasing chronic diseases to propel the demand for immunoassay market
According to Fact.MR, in 2021, North America had the largest revenue share of 35.0%, and it is expected to continue dominating the market throughout the study period. With nearly two-fifths of the global immunoassay market, the region will remain the market leader. An increase in the incidence of cancer as well as the ease of acquiring technologically advanced diagnostic techniques may be responsible for this rise in demand of this market.
The region has also witnessed a significant increase due to the rise in chronic and infectious diseases, the growing geriatric population and well-developed healthcare infrastructure and advances in medical technology. The region also faces a high incidence of infectious diseases, such as HIV, tuberculosis, and influenza, which increases the demand for detection and treatment.
Approximately six out of ten Americans suffer from chronic conditions like heart disease, stroke, cancer, and diabetes. Additionally, government organizations and pharmaceutical companies are increasing their R & D spending to address health issues like chronic diseases and diabetes. All these reasons combined together are giving way to increase the growth of the immunoassay market.
Is Asia Pacific a Lucrative Market for Immunoassay Sales?
Mergers and Acquisitions to Generate New Growth Avenues
The Asia-Pacific region promises rewarding opportunities, accumulating a market share of 34%. Leading manufacturers are merging and acquiring, while the healthcare and life sciences industry is booming.
In addition, the growing adoption of innovative laboratory methods for faster diagnosis and investigation of infectious and chronic disorders is another driver of market growth in the region. A key factor driving the market is the introduction of molecular kits and the growing use of reagents for diagnosis.
Market Share for the Immunoassay Market
| Attribute | Details |
|---|---|
| North America | 35% |
| Asia Pacific | 34% |
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Technology Type is likely to Acquire Maximum Market Gains?
Chemiluminescence Immunoassay (CLIA) is likely gain the maximum share
By technology type, Fact.MR, expects chemiluminescence immunoassay (CLIA) will account for nearly half of the global immunoassay market during the forecast period, growing at a CAGR of 6.6%. Benefits of using this technique include the use of fluorescence detection or light absorption, which is highly sensitive and can detect tiny amounts of the biological molecule.
In addition to this, its dynamic range is wider and its relationship between luminance intensity and substance concentration is linear. As a result of the enhanced reaction, intense light is emitted for a longer period of time, and the substrate need only be added minutes before detection.
By Application, which Category is likely to benefit the most?
Infectious diseases segment is forecast to grow in the Future
The infectious diseases segment is expected to grow at a CAGR of 6.5%, capturing 29.3% of the market. As a consequence of the ongoing COVID-19 pandemic, infectious diseases are becoming increasingly relevant.
The high share of infectious diseases segment can be attributed to increasing rates of HIV, influenza, malaria, and the new upcoming variants of COVID-19. Launches of new products in the field of infectious disease testing are driving the market further.
By End Use Industry, which Category is likely to benefit the Maximum?
Hospitals and blood banks are going to dominate this market
Hospitals are expected to dominate the market with an estimated 81% share, while blood banks are expected to grow at a CAGR of around 7.0%. Due to the rising number of infectious diseases detected at blood banks through screening and processing of donated blood, blood banks are expected to grow during the forecast period.
A major advantage of ELISA is that it is simple to use and does not require many specialized instruments or equipment. This is the reason it is widely used in blood banks. Hospitals are likely to see an increase in immunoassay testing as a result of increased demand for blood transfusions to treat infectious diseases. The blood bank segment will benefit from an increase in blood transfusions.
Competitive Landscape
The key players are taking on extensive initiatives to address the unmet needs of patients in the domain of immunoassays and stressing more on new product development, mergers and acquisitions, and regional expansion.
- Molecular biology subsidiary BioFire Diagnostics, a subsidiary of BioMérieux SA, filed an application with the Food and Drug Administration in January 2020 for clearance of its BIOFIRE Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE BCID2 Panel has an expanded list of antibiotic resistance genes, considerably more pathogens, and several revised targets compared to the previous BIOFIRE BCID Panel.
- Siemens Healthineers announced in November 2020 that its SARS-CoV-2 IgG Antibody Test has been certified as a CE mark measurement of neutralizing antibodies. The test is an improved version of the COVID-19 antibody test it previously launched.
- Maglumi HIV Ab/Ag Combi CLIA kit, Snibe Diagnostics’ fourth-generation chemiluminescence immunoassay that can detect HIV-1 and HIV-2 antibodies as well as the HIV-1 p24 antigen, obtained CE marking in April 2021, allowing it to be sold in the European Union and other regions accepting the designation.
Key Segments Covered in the Immunoassay Market Report
-
By Technology Type :
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Linked Fluorescence Assay (ELFA)
- Enzyme-linked Immunosorbent Assay (ELISA)
- Radioimmunoassay (RIA)
- Others
-
By Product :
- Analyzer Immunoassay
- Consumable Immunoassay
-
By Application :
- Infectious Diseases
- Orthopedics
- Cardiology
- Oncology
- Endocrinology
- Other Applications
-
By End-User :
- Immunoassay for Blood Banks
- Immunoassay for Hospitals & Diagnostic Laboratories
- Immunoassay for Others (Pharmaceutical & Biotech Companies, Forensic Labs, Academic & Research Institutes, etc.)
-
By Region :
- North America
- Western Europe
- Asia Pacific
- Middle East & Africa
- Eastern Europe
- Latin America
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Market Dynamics
- 6. Global Market Analysis and Forecast, by Technology
- 6.1. Chemiluminescence Immunoassay (CLIA)
- 6.2. Enzyme-linked Immunosorbent Assay (ELISA)
- 6.3. Enzyme-linked Fluorescent Assay (ELFA)
- 6.4. Radioimmunoassay (RIA)
- 6.5. Others (Microarray, Immunofluorescence Assay, Biochip Assay, Counting Immunoassay)
- 7. Global Market Analysis and Forecast, by Product
- 7.1. Analyzer
- 7.2. Consumables
- 8. Global Market Analysis and Forecast, by Application
- 8.1. Infectious Disease
- 8.2. Endocrinology
- 8.3. Oncology
- 8.4. Cardiology
- 8.5. Orthopedics
- 8.6. Others (Autoimmune Disorders, Allergy, Therapeutic Drug Monitoring, Liver Diseases, Acid Base Tests, GI Stool Testing, etc.)
- 9. Global Market Analysis and Forecasts, by End-user
- 9.1. Hospitals and Diagnostics Laboratories
- 9.2. Blood Banks
- 9.3. Others (Academic & Research Institutes, Pharmaceutical & Biotech Companies)
- 10. Global Market Analysis and Forecasts, by Region
- 10.1. North America
- 10.2. Europe
- 10.3. Asia Pacific
- 10.4. Latin America
- 10.5. Middle East & Africa
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. Asia Pacific Market Analysis and Forecast
- 14. Latin America Market Analysis and Forecast
- 15. Middle East and Africa Market Analysis and Forecast
- 16. Competition Landscape
- 16.1. F. Hoffmann-La Roche Ltd.
- 16.2. Danaher Corporation
- 16.3. Abbott Laboratories
- 16.4. Siemens Healthineers (Siemens AG)
- 16.5. DiaSorin S.p.A.
- 16.6. Sysmex Corporation
- 16.7. bioMérieux SA
- 16.8. Ortho Clinical Diagnostics (a part of Carlyle Group)
- 16.9. Thermo Fisher Scientific, Inc.
- 16.10. Becton, Dickinson and Company
- 16.11. Merck KGaA
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 02: Global Market Size (US$ Mn) Forecast, by Product, 2022 to 2032
Table 03: Global Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 04: Global Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 05: Global Market Size (US$ Mn) Forecast, by Region, 2022 to 2032
Table 06: North America Market Value (US$ Mn) Forecast, by Country, 2022 to 2032
Table 07: North America Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 09: North America Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 10: North America Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 11: U.S. Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 12: U.S. Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 13: U.S. Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 14: U.S. Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 15: Canada Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 16: Canada Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 17: Canada Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 18: Canada Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 19: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 20: Europe Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 21: Europe Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 22: Europe Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 23: Europe Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 24: Germany Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 25: Germany Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 26: Germany Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 27: Germany Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 28: U.K. Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 29: U.K. Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 30: U.K. Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 31: U.K. Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 32: France Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 33: France Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 34: France Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 35: France Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 36: Italy Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 37: Italy Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 38: Italy Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 39: Italy Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 40: Spain Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 41: Spain Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 42: Spain Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 43: Spain Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 44: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 45: Asia Pacific Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 46: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 47: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 48: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 49: China Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 50: China Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 51: China Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 52: China Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 53: India Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 54: India Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 55: India Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 56: India Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 57: Japan Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 58: Japan Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 59: Japan Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 60: Japan Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 61: Australia & New Zealand Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 62: Australia & New Zealand Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 63: Australia & New Zealand Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 64: Australia & New Zealand Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 65: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 66: Latin America Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 67: Latin America Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 68: Latin America Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 69: Latin America Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 70: Brazil Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 71: Brazil Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 72: Brazil Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 73: Brazil Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 74: Mexico Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 75: Mexico Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 76: Mexico Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 77: Mexico Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 78: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 79: Middle East & Africa Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 80: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 81: Middle East & Africa Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 82: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 83: GCC Countries Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 84: GCC Countries Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 85: GCC Countries Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 86: GCC Countries Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 87: South Africa Market Size (US$ Mn) Forecast, by Technology, 2022 to 2032
Table 88: South Africa Market Value (US$ Mn) Forecast, by Product, 2022 to 2032
Table 89: South Africa Market Size (US$ Mn) Forecast, by Application, 2022 to 2032
Table 90: South Africa Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) Forecast, 2022 to 2032
Figure 02: Market Value Share, by Technology (2021)
Figure 03: Market Value Share, by Product (2021)
Figure 04: Market Value Share, by End-user (2021)
Figure 05: Market Value Share, by Application (2021)
Figure 06: Market Value Share, by Region (2021)
Figure 07: Global Market Value Share Analysis (US$ Mn), by Technology, 2022 and 2032
Figure 08: Global Market Attractiveness Analysis, by Technology, 2022 to 2032
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemiluminescence Immunoassay, 2022 to 2032
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme-linked Immunosorbent Assay, 2022 to 2032
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme Linked Fluorescent Assay, 2022 to 2032
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radioimmunoassay, 2022 to 2032
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022 to 2032
Figure 14: Global Market Value Share Analysis (US$ Mn), by Product, 2022 and 2032
Figure 15: Global Market Attractiveness Analysis, by Product, 2022 to 2032
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzer, 2022 to 2032
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2022 to 2032
Figure 18: Global Market Value Share Analysis (US$ Mn), by Application, 2022 and 2032
Figure 19: Global Market Attractiveness Analysis, by Application, 2022 to 2032
Figure 20: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Disease, 2022 to 2032
Figure 21: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2022 to 2032
Figure 22: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2022 to 2032
Figure 23: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2022 to 2032
Figure 24: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Orthopedics, 2022 to 2032
Figure 25: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022 to 2032
Figure 26: Global Market Value Share Analysis (US$ Mn), by End-user, 2022 and 2032
Figure 27: Global Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 28: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostic Laboratories, 2022 to 2032
Figure 29: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2022 to 2032
Figure 30: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022 to 2032
Figure 31: Global Market Value Share Analysis, by Region, 2022 and 2032
Figure 32: Global Market Attractiveness Analysis, by Region, 2022 to 2032
Figure 33: North America Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 34: North America Market Value Share Analysis (US$ Mn), by Country, 2022 and 2032
Figure 35: North America Market Attractiveness Analysis, by Country, 2022 to 2032
Figure 36: North America Market Value Share, by Technology, 2022 and 2032
Figure 37: North America Market Attractiveness, by Technology, 2022 to 2032
Figure 38: North America Market Value Share, by Product, 2022 and 2032
Figure 39: North America Market Attractiveness, by Product, 2022 to 2032
Figure 40: North America Market Value Share, by Application, 2022 and 2032
Figure 41: North America Market Attractiveness, by Application, 2022 to 2032
Figure 42: North America Market Value Share Analysis, by End-user, 2022 and 2032
Figure 43: North America Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 44: Europe Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 45: Europe Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2022 and 2032
Figure 46: Europe Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2032
Figure 47: Europe Market Value Share, by Technology, 2022 and 2032
Figure 48: Europe Market Attractiveness, by Technology, 2022 to 2032
Figure 49: Europe Market Value Share, by Product, 2022 and 2032
Figure 50: Europe Market Attractiveness, by Product, 2022 to 2032
Figure 51: Europe Market Value Share, by Application, 2022 and 2032
Figure 52: Europe Market Attractiveness, by Application, 2022 to 2032
Figure 53: Europe Market Value Share Analysis, by End-user, 2022 and 2032
Figure 54: Europe Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 55: Asia Pacific Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 56: Asia Pacific Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2022 and 2032
Figure 57: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2032
Figure 58: Asia Pacific Market Value Share, by Technology, 2022 and 2032
Figure 59: Asia Pacific Market Attractiveness, by Technology, 2022 to 2032
Figure 60: Asia Pacific Market Value Share, by Product, 2022 and 2032
Figure 61: Asia Pacific Market Attractiveness, by Product, 2022 to 2032
Figure 62: Asia Pacific Market Value Share, by Application, 2022 and 2032
Figure 63: Asia Pacific Market Attractiveness, by Application, 2022 to 2032
Figure 64: Asia Pacific Market Value Share Analysis, by End-user, 2022 and 2032
Figure 65: Asia Pacific Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 66: Latin America Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 67: Latin America Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2022 and 2032
Figure 68: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2032
Figure 69: Latin America Market Value Share, by Technology, 2022 and 2032
Figure 70: Latin America Market Attractiveness, by Technology, 2022 to 2032
Figure 71: Latin America Market Value Share, by Product, 2022 and 2032
Figure 72: Latin America Market Attractiveness, by Product, 2022 to 2032
Figure 73: Latin America Market Value Share, by Application, 2022 and 2032
Figure 74: Latin America Market Attractiveness, by Application, 2022 to 2032
Figure 75: Latin America Market Value Share Analysis, by End-user, 2022 and 2032
Figure 76: Latin America Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 77: Middle East & Africa Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 78: Middle East & Africa Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2022 and 2032
Figure 79: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022 to 2032
Figure 80: Middle East & Africa Market Value Share, by Technology, 2022 and 2032
Figure 81: Middle East & Africa Market Attractiveness, by Technology, 2022 to 2032
Figure 82: Middle East & Africa Market Value Share, by Product, 2022 and 2032
Figure 83: Middle East & Africa Market Attractiveness, by Product, 2022 to 2032
Figure 84: Middle East & Africa Market Value Share, by Application, 2022 and 2032
Figure 85: Middle East & Africa Market Attractiveness, by Application, 2022 to 2032
Figure 86: Middle East & Africa Market Value Share Analysis, by End-user, 2022 and 2032
Figure 87: Middle East & Africa Market Attractiveness Analysis, by End-user, 2022 to 2032
Figure 88: Global Market Share Analysis, by Company (2021)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what rate did the immunoassay market flourish from 2015-2021?
From 2015-2021, the immunoassay market grew at a 5.1% value CAGR.
What is the expected forecast CAGR for Immunoassay from 2022-2032?
From 2022-2032, immunoassay demand is likely to surge at a 6% CAGR.
What is the expected market value for the APAC Immunoassay Market?
By 2032, Fact.MR expects the APAC market for Immunoassay will grow at a CAGR of 7%.
Which end use industry will account for the maximum deployment of Immunoassay?
Hospitals will hold the maximum share of the market with a value of 81%.
What would be the growth rate of the chemiluminescence immunoassay segment during the forecast period?
The chemiluminescence immunoassay segment is expected to grow at a 6.6% CAGR during the forecast period 2022-2032.
By application type, which segment will hold the largest market share?
The infectious diseases segment will hold the largest market share of 29.3%.
Immunoassay Market